Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue 1, 2003, Pages 18-21

  Leporrier, Nathalie ^a   Herrou, Michel ^a   Morello, Rémy ^a   Leymarie, Pierre ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION; ARTICLE; BIRTH RATE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FETUS; FETUS DISEASE; FETUS WASTAGE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ABORTION, SPONTANEOUS; ADULT; DOWN SYNDROME; FEMALE; FETAL DEATH; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0037222566     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-0528.2003.01490.x     Document Type: Article

References (12)

1. Leporrier N., Herrou M., Leymarie P. Antenatal screening for Down's syndrome. BMJ. 305:1992;1017-1018.
2. Herrou M., Leporrier N., Leymarie P. Screening for fetal Down syndrome with maternal serum hCG and oestriol: a prospective study. Prenat Diagn. 12:1992;887-892.
3. Cuckle H.S., Wald N.J. Screening for Down's syndrome. Lilford R. Prenatal Diagnosis and Prognosis. 1990;67-91 Butterworth, London.
4. Morris J.K., Wald N.J., Watt H.C. Fetal loss in Down syndrome pregnancies. Prenat Diagn. 19:1999;142-145.
5. Palomaki B.S., Glenn E., Jame E., Haddow M.D. Maternal serum alpha-fetoprotein, age and down syndrome risk. Am J Obstet Gynecol. 156:1987;460-463.
6. Cuckle H.S., Wald N.J., Thompson S.G. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 94:1987;387-402.
7. Mutton D., Ide R.G., Alberman E. Trends in prenatal screening for and diagnosis of Down's syndrome: England and Wales 1989-1997. BMJ. 317:1998;922-923.
8. Huang T., Watt H., Wald Net al. Birth prevalence of Down's syndrome in England and Wales 1990 to 1997. N Engl J Med. 5:1998;213-214.
9. Snijders R.J.M., Noble P., Sebire N., Souka A., Nicolaides K.H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet. 352:1998;343-346.
10. Cuckle H. Down syndrome fetal loss rate in early pregnancy. Prenat Diagn. 19:1999;1175-1180.
11. Labbé S., Copin H., Choiset A., Girard S., Barbet J.P. Placenta et trisomies 13, 18, 21. J Gynecol Obstet Biol Reprod. 18:1989;989-996.
12. Roberts L., Sebire N.J., Fowler D., Nicolaides K.H. Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies. Placenta. 21(7):2000;678-683.